Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114885) titled 'Evaluating the Efficacy and Safety of Perfluorohexyloctane in Treating Antiglaucoma Drug-Related Dry Eye' on Dec. 18, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Tianjin Medical University Eye Hospital
Condition:
Dry Eye
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-12-31
Target Sample Size: Experimental group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300408
Published by HT Digital Content Services with permission from Health Daily Digest....